Prenetics與鄭志剛旗下Artisan(ARTAU.US)之擬議業務合併登記聲明生效 合併後證券料5月中上市
基因及診斷檢測公司PreneticsPrenetics宣布,美國證監會已對Prenetics與新世界(00017.HK)執行副主席兼行政總裁鄭志剛創辦及私人持有的特殊目的收購公司Artisan Acquisition Corp.(ARTAU.US)之擬議業務合併,以F-4表格形式呈交的登記聲明宣告生效。
Artisan將於今年5月9日安排召開特別股東大會,尋求股東批准與Prenetics的擬議業務合併。倘若本次業務合併獲Artisan股東及納斯達克批准,並滿足完成業務合併的其他條件後,合併後公司的證券料於今年5月中在納斯達克以股票代碼「PRE」進行交易。
此次業務合併估算Prenetics的企業價值為12.5億美元,倘若本次業務合併完成並上市後,Prenetics將成為首家在納斯達克上市的香港獨角獸。視乎Artisan股東的股權贖回情況,Prenetics在業務合併完成後可獲得達4.59億美元的款項,當中包括來自Artisan 信託賬戶的3.39 億美元,以及1.2億美元的PIPE資金和遠期購買協議。
Prenetics公司2021年全年收入2.75億美元,按年增長 323%,高過之前公布的2.05億美元全年收入指引;全年經調整除息稅折舊攤銷前盈利為4,090萬美元,按年增長 536%。公司將於今年上半年推出一系列新產品,包括ColoClear無創大腸癌FIT-DNA篩查測試,以及Circle Snapshot居家血液檢測、方便用戶的血樣採集和檢測結果傳遞系統。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.